TENET HEALTHCARE CORP
THCNYSE
$194.91
↓ -2.2%Jul 17 close · end-of-day
Price
1Y↑ +12.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$17.1B
Enterprise Value
$27.3B
P/E
10.1
P/S
0.8
P/B
3.5
EV/EBITDA
5.8
PEG
0.2
FCF Yield
19.6%
Dividend Yield
—
Revenue (TTM)
$21.5B
Net Income (TTM)
—
Free Cash Flow (TTM)
$3.3B
Gross Margin
—
Operating Margin
18.0%
Net Margin
—
ROE
—
ROIC
21.5%
Debt / Equity
2.7
Net Cash
-$10.2B
Return 1Y
+11.3%
Company profile
Tenet Healthcare Corporation operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities.
- CEO
- Saumya Sutaria
- Sector
- Services
- Industry
- Healthcare
- Employees
- 102,400
- Headquarters
- Texas
- Website
- tenethealth.com
Earnings
THC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$5.4B↑ +2.8%
Diluted EPS$8.01↑ +87.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $17.6B | $19.5B | $19.2B | $20.6B | $20.7B | $21.3B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $2.0B | $2.9B | $2.3B | $2.5B | $6.0B | $3.5B |
| Net income | — | $1.5B | $1.0B | $1.3B | $4.1B | $2.4B |
| Diluted EPS | $3.75 | $8.42 | $3.79 | $5.71 | $32.70 | $15.49 |
| Operating cash flow | $3.4B | $1.6B | $1.1B | $2.4B | $2.0B | $3.5B |
| Free cash flow | $2.9B | $910.0M | $321.0M | $1.6B | $1.1B | $2.5B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 11.3% | 14.7% | 12.2% | 12.2% | 28.8% | 16.5% |
| Net margin | — | 7.6% | 5.2% | 6.4% | 19.7% | 11.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $5.1B | $5.1B | $5.2B | $5.3B | $5.3B | $5.5B | $5.4B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $761.0M | $1.1B | $821.0M | $943.0M | $823.0M | $889.0M | $853.0M | $1.3B |
| Net income | — | — | — | — | — | — | — | — |
| Diluted EPS | $2.64 | $4.89 | $3.79 | $4.27 | $3.14 | $3.86 | $4.22 | $8.01 |
| Operating cash flow | $747.0M | $1.0B | -$331.0M | $815.0M | $936.0M | $1.1B | $731.0M | $1.6B |
| Free cash flow | $602.0M | $829.0M | -$661.0M | $642.0M | $743.0M | $778.0M | $367.0M | $1.5B |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 14.9% | 21.2% | 16.2% | 18.1% | 15.6% | 16.8% | 15.4% | 24.1% |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 19, 2026
Jul 17, 2026
Jul 16, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.